-

Nourish Shows 68% Six-Month GLP-1 Persistence, Outperforming Industry Benchmarks

Findings demonstrate strong signal that dietitian-led care improves GLP-1 persistence and supports long-term health outcomes

NEW YORK--(BUSINESS WIRE)--Despite the promise of GLP-1s as an effective tool for weight loss, patient persistence on the medication is a barrier to long-term outcomes. Today, Nourish, the only dietitian-led metabolic health clinic in the country, released data showing that 68% of Nourish patients remained on GLP-1 therapy at six months, compared to a 46% industry benchmark. Full results are available in Nourish’s new whitepaper: GLP-1 Persistence through Dietitian-Led Care.

The Nourish GLP-1 Companion Care program pairs evidence-based nutrition therapy delivered by registered dietitians with wraparound physician support. Patients follow a structured clinical pathway and receive personalized nutrition support tailored to their individual needs, helping them achieve their treatment goals while mitigating side effects. This integrated approach is designed to maximize the efficacy and durability of GLP-1 treatment.

Nourish’s data demonstrates that embedding nutrition care directly into GLP-1 treatment improves persistence over time, which in turn helps patients build the sustainable habits that support long-term outcomes.

“We find many patients struggle to stay on GLP-1s long enough to see results due to side effects and lack of support,” said Aidan Dewar, co-founder and CEO of Nourish. “When patients receive personalized, dietitian-led care alongside GLP-1s, they’re better able to tolerate the medications, manage side effects, and ultimately build habits that lead to more durable outcomes.”

Nourish supports patients across the full GLP-1 journey:

  • Nutrition-first care for patients not on medication
  • Companion care alongside medication to improve persistence and manage side effects
  • Off-ramp support to sustain outcomes after medication discontinuation

By pairing medication with ongoing nutrition care, Nourish helps patients stay on therapy longer and achieve better long-term outcomes, while enabling health plans and employers to maximize the value of their GLP-1 investment.

To learn more, read the full whitepaper: GLP-1 Persistence through Dietitian-Led Care.

About Nourish

Nourish is tackling America’s healthcare crisis by addressing the root cause of metabolic disease through insurance-covered, AI-powered virtual nutrition care. The company combines personalized visits with registered dietitians (RDs), labs, and an AI-native technology platform to deliver scalable, effective treatment for chronic conditions.

As the only dietitian-led metabolic health clinic in the country, Nourish makes it easy for patients to get matched to an expert provider, access care from home, and improve their health — typically at no cost. Through partnerships with all major insurers, as well as health systems and local providers, Nourish is available to hundreds of millions of patients across all 50 states. Nourish is actively hiring across clinical and business roles — learn more at usenourish.com.

Contacts

Press contact: Britta Franson, britta.franson@usenourish.com

Nourish


Release Versions

Contacts

Press contact: Britta Franson, britta.franson@usenourish.com

More News From Nourish

Nourish Announces Clinical Outcomes Model, Tying Fees to Performance in the First Outcomes-Based Approach for Dietitian-Led Metabolic Care

NEW YORK--(BUSINESS WIRE)--Nourish, the country's largest dietitian-led metabolic health clinic, today announced the Nourish Clinical Outcomes Model: an integrated model across care delivery, product, and data focused on the continuous improvement of patient outcomes, both with and without medications.89% of Nourish patients have at least one metabolic condition, among the most complex and costly conditions to treat. Driving measurable outcomes for this high-acuity population requires a coordina...

Nourish Shows Patients Completing 6+ Dietitian Appointments Achieve 2.3x Greater Weight Loss

NEW YORK--(BUSINESS WIRE)--Nourish, the country’s largest dietitian-led metabolic health clinic, released a new whitepaper today demonstrating that high-acuity patients who engage more with the Nourish program achieve stronger metabolic outcomes. Drawing from a real-world analysis of Nourish patients, the whitepaper highlights a clear dose-response relationship between engagement and outcomes: high-acuity patients who completed more appointments achieved greater weight loss and more significant...

Nourish Raises $100M Series C to Reverse Chronic Disease with AI-Native Metabolic Clinic

NEW YORK--(BUSINESS WIRE)--Nourish, the country’s largest dietitian-led metabolic health clinic, today announced its $100 million Series C, bringing total funding to $215 million. The round was led by Menlo Ventures, with participation from Thrive Capital, Index Ventures, J.P. Morgan Growth Equity Partners, Maverick Ventures, Y Combinator, BoxGroup, Atomico, Daybreak, and Operator Partners. The funding will be used to grow Nourish's clinical network, accelerate investment in AI agents for patie...
Back to Newsroom